Vaso Active Pharmaceuticals Inc. Revamps Its Existing And Adopts New Corporate Governance And Compliance Policies
10/19/2005 5:12:33 PM
DANVERS, Mass.--(BUSINESS WIRE)--Jan. 25, 2005--Vaso Active Pharmaceuticals, Inc. (Vaso Active) (VAPH.pk) of Danvers, Massachusetts, announced today on January 19, 2005, the Company's Board of Directors revised certain existing and approved new corporate governance policies and procedures of the Company. Specifically, the Board adopted Compensation Committee and Nominating and Corporate Governance Charters; made revisions to the existing Audit Committee Charter and Code of Ethics; adopted Policies and Procedures Regarding Shareholder Communications with the Board of Directors, and Nominating and Corporate Governance Committee Policies and Procedures for the Consideration of Board of Director Candidates. The purpose of this Board action was to strengthen the Company's corporate governance and compliance structures and to reiterate the Board's commitment to fostering sound and reliable corporate governance environment.
comments powered by